Bloomberg Law
Oct. 13, 2020, 7:46 PM

Cytiva to Manufacture Covid Vaccine Supplies Under HHS Contract

Cheryl Bolen
Cheryl Bolen
White House Reporter

Massachusetts-based Cytiva will expand its manufacturing capacity for products essential to producing Covid-19 vaccines under an agreement announced Tuesday by the Department of Health and Human Services.

The agreement with Cytiva is the latest to increase manufacturing capacity in the U.S. to aid in developing and administering Covid-19 vaccines and therapeutics. The Trump administration has been struggling since the start of the pandemic to fill supply shortages.

To date, the federal government has provided more than $1.1 billion to purchase needles, syringes, vials, and supply kits, and to expand the capacity to manufacture these ancillary supplies for Covid-19 vaccines and ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.